** Shares in Danish food ingredients maker Chr Hansen
CHRH.CO rise nearly 6% after Q1 results beating forecasts
** The company's quarterly revenue of DKK 268 mln and EBIT
of DKK 65 mln came in above consensus estimates urn:newsml:reuters.com:*:nASN0021OI
** Outlook remains unchanged, in line with consensus
expectations
** Chr Hansen's CEO says the encouraging start to the year
underlines the strength of company's 2025 strategy
differentiating it as a bioscience company focused on microbial
and fermentation technology platforms
** JPM notes the headline beat but given reiterated FY22
guide it expects limited changes to consensus EPS
** The stock, on track for its best day in a year, is among
top performers on STOXX 600 .STOXX index
(Reporting by Aleksandra Jasiurska)
((Aleksandra.jasiurska@thomsonreuters.com))